Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Statistics

Total Valuation

TLV:TEVA has a market cap or net worth of ILS 74.03 billion. The enterprise value is 124.23 billion.

Market Cap	74.03B
Enterprise Value	124.23B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.15B
Shares Outstanding	n/a
Shares Change (YoY)	+1.25%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.14B

Valuation Ratios

PE Ratio	n/a
Forward PE	7.68
PS Ratio	1.32
PB Ratio	3.21
P/TBV Ratio	n/a
P/FCF Ratio	24.69
P/OCF Ratio	15.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.15, with an EV/FCF ratio of 41.43.

EV / Earnings	-234.84
EV / Sales	2.29
EV / EBITDA	8.15
EV / EBIT	10.87
EV / FCF	41.43

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 2.57.

Current Ratio	1.06
Quick Ratio	0.48
Debt / Equity	2.57
Debt / EBITDA	3.76
Debt / FCF	19.71
Interest Coverage	3.59

Financial Efficiency

Return on equity (ROE) is -2.42% and return on invested capital (ROIC) is 8.77%.

Return on Equity (ROE)	-2.42%
Return on Assets (ROA)	5.37%
Return on Invested Capital (ROIC)	8.77%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	1.51M
Profits Per Employee	-14,297
Employee Count	35,686
Asset Turnover	0.41
Inventory Turnover	2.26

Taxes

In the past 12 months, TLV:TEVA has paid 316.71 million in taxes.

Income Tax	316.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.85%
50-Day Moving Average	6,249.76
200-Day Moving Average	6,091.53
Relative Strength Index (RSI)	53.54
Average Volume (20 Days)	1,450,838

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.42

Income Statement

In the last 12 months, TLV:TEVA had revenue of ILS 56.02 billion and -528.98 million in losses. Loss per share was -0.47.

Revenue	56.02B
Gross Profit	27.79B
Operating Income	11.79B
Pretax Income	-229.11M
Net Income	-528.98M
EBITDA	15.24B
EBIT	11.79B
Loss Per Share	-0.47

Balance Sheet

The company has 7.28 billion in cash and 59.10 billion in debt, giving a net cash position of -51.82 billion.

Cash & Cash Equivalents	7.28B
Total Debt	59.10B
Net Cash	-51.82B
Net Cash Per Share	n/a
Equity (Book Value)	23.03B
Book Value Per Share	20.05
Working Capital	2.56B

Cash Flow

In the last 12 months, operating cash flow was 4.68 billion and capital expenditures -1.68 billion, giving a free cash flow of 3.00 billion.

Operating Cash Flow	4.68B
Capital Expenditures	-1.68B
Free Cash Flow	3.00B
FCF Per Share	n/a

Margins

Gross margin is 49.60%, with operating and profit margins of 21.05% and -0.94%.

Gross Margin	49.60%
Operating Margin	21.05%
Pretax Margin	-0.41%
Profit Margin	-0.94%
EBITDA Margin	27.20%
EBIT Margin	21.05%
FCF Margin	5.35%

Dividends & Yields

TLV:TEVA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.25%
Shareholder Yield	-1.25%
Earnings Yield	-0.71%
FCF Yield	4.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 27, 2004. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2004
Split Type	Forward
Split Ratio	2

Scores

TLV:TEVA has an Altman Z-Score of 0.57 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.57
Piotroski F-Score	6